Pestalozzi has advised Condecta; VISCHER advises TOI TOI. Condecta, the Swiss market leader in mobile room solutions, has completed the sale of its MobiToil business to...
Condecta Sells MobiToil Business to TOI TOI
Burckhardt of Switzerland AG Enters Strategic Partnership with R.K. Texparts
VISCHER has advised Burckhardt of Switzerland AG. Burckhardt of Switzerland AG, a leader in perforation and fibrillation for technical textiles and flexible films based in Switzerland,...
FimmCyte and Gedeon Richter Enter Strategic Research Collaboration in Endometriosis Therapies
VISCHER has advised FimmCyte. FimmCyte AG, a Swiss biotechnology company, has established a strategic research collaboration and option-to-license agreement with Gedeon Richter Plc., a major Hungarian...
Matignon Group Acquires Praxis am Zeltweg Medical Aesthetics Center in Zurich
VISCHER has advised Matignon Group. Matignon Group has completed the acquisition of assets and agreements related to Praxis am Zeltweg, a well-established center focused on medical...
Virometix AG Secures $15 Million in Financing Round
VISCHER has advised Virometix AG. Virometix AG, a clinical-stage biotechnology company specializing in fully synthetic vaccines, has completed a $15 million financing round with participation from...
Oncobit and ID Solutions Form Strategic Oncology Diagnostics Partnership
VISCHER has advised Oncobit. Oncobit, a Swiss company specializing in precision oncology, has entered into a strategic partnership with ID Solutions, a French developer of innovative...
ASTRA Therapeutics Secures CHF 7.75 Million in Seed Financing
VISCHER has advised ASTRA Therapeutics SA. ASTRA Therapeutics SA, a start-up specializing in the development of precision drugs targeting eukaryotic pathogens, has announced the successful completion...
FoRx Therapeutics Secures USD 50 Million in Series A Financing to Advance Phase 1 Clinical Development
VISCHER has advised FoRx Therapeutics AG. FoRx Therapeutics AG, a clinical-stage biotechnology company, has completed a USD 50 million Series A financing round. The funding round...
Aukera Therapeutics Secures CHF 4.5 Million in Funding and Expands Board
VISCHER has advised Aukera Therapeutics. Aukera Therapeutics, a preclinical-stage biotech spin-off from the University of Basel, has raised approximately CHF 4.5 million in funding and announced...
Afinum Acquires Majority Stake in Ergon Informatik with Financing Support
VISCHER has advised Afinum. Niederer Kraft Frey has advised Zürcher Kantonalbank and Luzerner Kantonalbank AG. Schellenberg Wittmer acted as legal counsel to the sellers. Afinum has...
Comitis Capital Acquires Threema
Pestalozzi has advised Comitis Capital. VISCHER advised AFINUM. Comitis Capital has entered into an agreement to acquire Threema, a transaction announced on 12 January 2026. The...
Oculis Holding AG Secures USD 110 Million Through Share Offerings
VISCHER AG has advised Oculis Holding AG. Oculis Holding AG, a global biopharmaceutical company listed on Nasdaq and XICE, has announced the successful pricing of offerings...